Webinar: FDA’s MedWatch Adverse Reporting Program

On Tuesday, February 7, at 1:00 p.m. ET, join the FDA’s Division of Drug Information for a webinar on reporting adverse events via MedWatch. Specifically, the webinar will cover:

  • The roles of the FDA Office of Health and Constituent Affairs and the MedWatch program
  • How to advance and be involved with FDA messaging
  • Types of adverse events and product problems that should be reported via MedWatch and how to do that

This session will be presented by Teresa Rubio, PharmD, health programs coordinator at the FDA. To register, please visit the FDA website.